| Literature DB >> 30979585 |
Jingjin Ding1, Xing Pan2, Lijie Du3, Qing Yao4, Juan Xue3, Hongwei Yao5, Da-Cheng Wang6, Shan Li7, Feng Shao8.
Abstract
Enteropathogenic E. coli NleB and related type III effectors catalyze arginine GlcNAcylation of death domain (DD) proteins to block host defense, but the underlying mechanism is unknown. Here we solve crystal structures of NleB alone and in complex with FADD-DD, UDP, and Mn2+ as well as NleB-GlcNAcylated DDs of TRADD and RIPK1. NleB adopts a GT-A fold with a unique helix-pair insertion to hold FADD-DD; the interface contacts explain the selectivity of NleB for certain DDs. The acceptor arginine is fixed into a cleft, in which Glu253 serves as a base to activate the guanidinium. Analyses of the enzyme-substrate complex and the product structures reveal an inverting sugar-transfer reaction and a detailed catalytic mechanism. These structural insights are validated by mutagenesis analyses of NleB-mediated GlcNAcylation in vitro and its function in mouse infection. Our study builds a structural framework for understanding of NleB-catalyzed arginine GlcNAcylation of host death domain.Entities:
Keywords: GlcNAcylation; arginine modification; bacteria-host interaction; bacterial virulence; death domain; death receptor signaling; glycosyltransferase; protein glycosylation; type III secretion system
Mesh:
Substances:
Year: 2019 PMID: 30979585 DOI: 10.1016/j.molcel.2019.03.028
Source DB: PubMed Journal: Mol Cell ISSN: 1097-2765 Impact factor: 17.970